Question

The study randomly assigned 13,608 patients with moderate-to-high-risk of acute coronary syndromes with percutaneous coronary intervention to receive either Prasugrel (a 60 mg loading dose and a 10 mg daily maintenance dose), for 6 to 15 months Clopidogrel (a 300 mg loading dose and a 75 mg maintenance dose), for 6 to 15 months The primary efficacy endpoint was death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. The key was major bleeding. Which of the following is/are the dependent variables? (SELECT ALL THAT APPLY) Select one or more: a. Death from cardiovascular causes b. Nonfatal stroke C.Prasugrel (a 60-mg loading dose and a 10-mg daily maintenance dose) d. Clopidogral (a 300-mg loading dose and a 75-mg daily maintenance dose) e.Nonfatal myocardial infarction

Answer 1

answer is ) key safety and point is major bleeding because prasugrel and clopidogrel is anti platelet and prevent formation of blood clot who have a long time duration is taken so major bleeding disorder developed